Logo image of BAKKA.OL

BAKKAFROST P/F (BAKKA.OL) Stock Fundamental Analysis

Europe - OSL:BAKKA - FO0000000179 - Common Stock

473.7 NOK
-13.3 (-2.73%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BAKKA. BAKKA was compared to 57 industry peers in the Food Products industry. Both the profitability and the financial health of BAKKA get a neutral evaluation. Nothing too spectacular is happening here. BAKKA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

BAKKA had positive earnings in the past year.
BAKKA had a positive operating cash flow in the past year.
In the past 5 years BAKKA has always been profitable.
BAKKA had a positive operating cash flow in each of the past 5 years.
BAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFBAKKA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 1.30%, BAKKA is doing worse than 66.67% of the companies in the same industry.
The Return On Equity of BAKKA (2.19%) is worse than 71.93% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.10%, BAKKA is in line with its industry, outperforming 45.61% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BAKKA is in line with the industry average of 6.48%.
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROIC 4.1%
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
BAKKA.OL Yearly ROA, ROE, ROICBAKKA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

BAKKA has a Profit Margin of 3.49%. This is comparable to the rest of the industry: BAKKA outperforms 49.12% of its industry peers.
BAKKA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 13.65%, BAKKA belongs to the best of the industry, outperforming 82.46% of the companies in the same industry.
BAKKA's Operating Margin has declined in the last couple of years.
BAKKA's Gross Margin of 71.02% is amongst the best of the industry. BAKKA outperforms 98.25% of its industry peers.
BAKKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
BAKKA.OL Yearly Profit, Operating, Gross MarginsBAKKA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BAKKA is destroying value.
Compared to 1 year ago, BAKKA has about the same amount of shares outstanding.
BAKKA has more shares outstanding than it did 5 years ago.
BAKKA has a better debt/assets ratio than last year.
BAKKA.OL Yearly Shares OutstandingBAKKA.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BAKKA.OL Yearly Total Debt VS Total AssetsBAKKA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

BAKKA has an Altman-Z score of 2.87. This is not the best score and indicates that BAKKA is in the grey zone with still only limited risk for bankruptcy at the moment.
BAKKA has a better Altman-Z score (2.87) than 75.44% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that BAKKA is not too dependend on debt financing.
BAKKA's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. BAKKA outperforms 59.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 2.87
ROIC/WACC0.5
WACC8.17%
BAKKA.OL Yearly LT Debt VS Equity VS FCFBAKKA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BAKKA has a Current Ratio of 12.90. This indicates that BAKKA is financially healthy and has no problem in meeting its short term obligations.
BAKKA has a better Current ratio (12.90) than 100.00% of its industry peers.
A Quick Ratio of 2.27 indicates that BAKKA has no problem at all paying its short term obligations.
BAKKA's Quick ratio of 2.27 is amongst the best of the industry. BAKKA outperforms 92.98% of its industry peers.
Industry RankSector Rank
Current Ratio 12.9
Quick Ratio 2.27
BAKKA.OL Yearly Current Assets VS Current LiabilitesBAKKA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

BAKKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -46.96%.
BAKKA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.36% yearly.
BAKKA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.08%.
Measured over the past years, BAKKA shows a quite strong growth in Revenue. The Revenue has been growing by 10.21% on average per year.
EPS 1Y (TTM)-46.96%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-102.02%
Revenue 1Y (TTM)-15.08%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-23.83%

3.2 Future

Based on estimates for the next years, BAKKA will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.19% on average per year.
The Revenue is expected to grow by 8.18% on average over the next years. This is quite good.
EPS Next Y-36.65%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
EPS Next 5YN/A
Revenue Next Year-5.48%
Revenue Next 2Y5.99%
Revenue Next 3Y8.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BAKKA.OL Yearly Revenue VS EstimatesBAKKA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
BAKKA.OL Yearly EPS VS EstimatesBAKKA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.91, which means the current valuation is very expensive for BAKKA.
Based on the Price/Earnings ratio, BAKKA is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
BAKKA is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 15.03, BAKKA is valued correctly.
BAKKA's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, BAKKA is valued rather cheaply.
Industry RankSector Rank
PE 29.91
Fwd PE 15.03
BAKKA.OL Price Earnings VS Forward Price EarningsBAKKA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BAKKA is valued a bit more expensive than 63.16% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.21
BAKKA.OL Per share dataBAKKA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

BAKKA's earnings are expected to grow with 13.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.52%
EPS Next 3Y13.19%

4

5. Dividend

5.1 Amount

BAKKA has a Yearly Dividend Yield of 2.75%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.35, BAKKA pays a bit more dividend than its industry peers.
BAKKA's Dividend Yield is comparable with the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 2.75%

5.2 History

The dividend of BAKKA has a limited annual growth rate of 3.15%.
Dividend Growth(5Y)3.15%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

219.43% of the earnings are spent on dividend by BAKKA. This is not a sustainable payout ratio.
BAKKA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP219.43%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
BAKKA.OL Yearly Income VS Free CF VS DividendBAKKA.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B -3B
BAKKA.OL Dividend Payout.BAKKA.OL Dividend Payout, showing the Payout Ratio.BAKKA.OL Dividend Payout.PayoutRetained Earnings

BAKKAFROST P/F

OSL:BAKKA (11/14/2025, 7:00:00 PM)

473.7

-13.3 (-2.73%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-04 2025-11-04
Earnings (Next)02-16 2026-02-16/amc
Inst Owners55.36%
Inst Owner ChangeN/A
Ins Owners16.06%
Ins Owner ChangeN/A
Market Cap28.13B
Revenue(TTM)6.53B
Net Income(TTM)228.10M
Analysts75.56
Price Target524.66 (10.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.75%
Yearly Dividend13.66
Dividend Growth(5Y)3.15%
DP219.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.41%
Min EPS beat(2)-106.11%
Max EPS beat(2)-14.72%
EPS beat(4)0
Avg EPS beat(4)-43.68%
Min EPS beat(4)-106.11%
Max EPS beat(4)-2.8%
EPS beat(8)2
Avg EPS beat(8)-25.32%
EPS beat(12)3
Avg EPS beat(12)-21.81%
EPS beat(16)3
Avg EPS beat(16)-24.75%
Revenue beat(2)0
Avg Revenue beat(2)-17.2%
Min Revenue beat(2)-21.74%
Max Revenue beat(2)-12.67%
Revenue beat(4)0
Avg Revenue beat(4)-16.42%
Min Revenue beat(4)-21.74%
Max Revenue beat(4)-12.34%
Revenue beat(8)1
Avg Revenue beat(8)-10.61%
Revenue beat(12)4
Avg Revenue beat(12)-4.72%
Revenue beat(16)5
Avg Revenue beat(16)-5.03%
PT rev (1m)5.16%
PT rev (3m)-9.71%
EPS NQ rev (1m)-35.69%
EPS NQ rev (3m)-63.54%
EPS NY rev (1m)-10.72%
EPS NY rev (3m)-46.86%
Revenue NQ rev (1m)3.44%
Revenue NQ rev (3m)1.24%
Revenue NY rev (1m)-1.71%
Revenue NY rev (3m)-4.75%
Valuation
Industry RankSector Rank
PE 29.91
Fwd PE 15.03
P/S 2.75
P/FCF N/A
P/OCF 17.49
P/B 1.73
P/tB 3.04
EV/EBITDA 14.21
EPS(TTM)15.84
EY3.34%
EPS(NY)31.51
Fwd EY6.65%
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)27.09
OCFY5.72%
SpS172
BVpS274.59
TBVpS155.85
PEG (NY)N/A
PEG (5Y)N/A
Graham Number312.83
Profitability
Industry RankSector Rank
ROA 1.3%
ROE 2.19%
ROCE 5.17%
ROIC 4.1%
ROICexc 4.15%
ROICexgc 5.64%
OM 13.65%
PM (TTM) 3.49%
GM 71.02%
FCFM N/A
ROA(3y)5.68%
ROA(5y)5.43%
ROE(3y)9.21%
ROE(5y)8.65%
ROIC(3y)6.71%
ROIC(5y)5.53%
ROICexc(3y)6.94%
ROICexc(5y)5.73%
ROICexgc(3y)9.65%
ROICexgc(5y)8.22%
ROCE(3y)8.44%
ROCE(5y)6.96%
ROICexgc growth 3Y13.09%
ROICexgc growth 5Y-10.07%
ROICexc growth 3Y16.55%
ROICexc growth 5Y-6.46%
OM growth 3Y13.95%
OM growth 5Y-7.81%
PM growth 3Y-19.8%
PM growth 5Y-13%
GM growth 3Y1.78%
GM growth 5Y0.18%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 2.98
Cap/Depr 145.81%
Cap/Sales 16.72%
Interest Coverage 250
Cash Conversion 62.7%
Profit Quality N/A
Current Ratio 12.9
Quick Ratio 2.27
Altman-Z 2.87
F-Score5
WACC8.17%
ROIC/WACC0.5
Cap/Depr(3y)180.8%
Cap/Depr(5y)188.01%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.96%
EPS 3Y21.53%
EPS 5Y-1.36%
EPS Q2Q%-102.02%
EPS Next Y-36.65%
EPS Next 2Y4.52%
EPS Next 3Y13.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.08%
Revenue growth 3Y9.71%
Revenue growth 5Y10.21%
Sales Q2Q%-23.83%
Revenue Next Year-5.48%
Revenue Next 2Y5.99%
Revenue Next 3Y8.18%
Revenue Next 5YN/A
EBIT growth 1Y-38.14%
EBIT growth 3Y25.01%
EBIT growth 5Y1.6%
EBIT Next Year23.25%
EBIT Next 3Y28.27%
EBIT Next 5YN/A
FCF growth 1Y-138.63%
FCF growth 3Y431.02%
FCF growth 5YN/A
OCF growth 1Y-29.4%
OCF growth 3Y27.94%
OCF growth 5Y17.84%

BAKKAFROST P/F / BAKKA.OL FAQ

What is the fundamental rating for BAKKA stock?

ChartMill assigns a fundamental rating of 5 / 10 to BAKKA.OL.


What is the valuation status of BAKKAFROST P/F (BAKKA.OL) stock?

ChartMill assigns a valuation rating of 2 / 10 to BAKKAFROST P/F (BAKKA.OL). This can be considered as Overvalued.


How profitable is BAKKAFROST P/F (BAKKA.OL) stock?

BAKKAFROST P/F (BAKKA.OL) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for BAKKA stock?

The Price/Earnings (PE) ratio for BAKKAFROST P/F (BAKKA.OL) is 29.91 and the Price/Book (PB) ratio is 1.73.


Can you provide the dividend sustainability for BAKKA stock?

The dividend rating of BAKKAFROST P/F (BAKKA.OL) is 4 / 10 and the dividend payout ratio is 219.43%.